URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Shreedevi Pandya

Concepts (249)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Muscular Dystrophy, Duchenne
13
2001
51
3.170
Why?
Muscular Dystrophies
23
1981
184
1.670
Why?
Prednisone
12
1981
177
1.600
Why?
Dermatomyositis
1
2011
29
0.790
Why?
Glucocorticoids
2
2009
166
0.750
Why?
Myotonia
3
2007
45
0.740
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2011
94
0.730
Why?
Genetic Vectors
3
1999
339
0.730
Why?
Receptors, Tumor Necrosis Factor
1
2011
143
0.720
Why?
Muscular Dystrophy, Facioscapulohumeral
2
2001
25
0.710
Why?
Severity of Illness Index
6
1996
919
0.700
Why?
Immunoglobulin G
1
2011
482
0.670
Why?
Quality of Life
5
2009
509
0.650
Why?
Adolescent
30
1981
4752
0.610
Why?
Genetic Predisposition to Disease
1
2008
329
0.560
Why?
Child
27
1983
4086
0.530
Why?
Myositis, Inclusion Body
2
2008
25
0.520
Why?
Humans
57
1981
36400
0.510
Why?
Male
44
1981
19713
0.500
Why?
Simian immunodeficiency virus
2
1999
30
0.480
Why?
Lentivirus
2
1999
27
0.470
Why?
Young Adult
7
2008
1074
0.470
Why?
Adult
29
1984
11345
0.460
Why?
Mutation
2
2008
1229
0.460
Why?
Myotonic Dystrophy
4
1989
209
0.440
Why?
Amphotericin B
1
2002
27
0.430
Why?
Mycoses
1
2002
31
0.420
Why?
Population Surveillance
4
2006
137
0.420
Why?
Voice
1
2011
7
0.400
Why?
Antifungal Agents
1
2002
62
0.400
Why?
Gene Products, rev
1
2001
3
0.400
Why?
Telephone
1
2011
22
0.400
Why?
Child, Preschool
22
1983
2612
0.400
Why?
Spumavirus
1
2001
1
0.390
Why?
Hand Strength
3
2001
34
0.390
Why?
HIV-1
3
1999
538
0.390
Why?
Medical Records
1
2011
125
0.390
Why?
Middle Aged
19
1989
9877
0.380
Why?
Gene Deletion
3
1996
205
0.370
Why?
Treatment Outcome
8
1997
2623
0.370
Why?
Muscle Strength
2
2007
26
0.350
Why?
Double-Blind Method
14
1984
998
0.350
Why?
Dose-Response Relationship, Drug
4
1991
1138
0.350
Why?
Female
24
1991
19826
0.330
Why?
Pregnenediones
2
2005
8
0.320
Why?
Membrane Glycoproteins
1
2001
365
0.310
Why?
Genotype
3
1996
487
0.310
Why?
Affect
2
2010
78
0.300
Why?
Muscles
13
1981
348
0.300
Why?
Pilot Projects
5
1997
441
0.270
Why?
Drug Administration Schedule
4
1991
369
0.270
Why?
Isometric Contraction
3
1994
47
0.250
Why?
Muscle Weakness
2
2007
37
0.250
Why?
Physical Therapy Modalities
3
1985
28
0.250
Why?
Muscle, Skeletal
3
2006
437
0.240
Why?
Shoulder
3
1994
23
0.240
Why?
Muscular Diseases
2
1981
68
0.230
Why?
Caregivers
2
2011
75
0.230
Why?
Cohort Studies
4
2008
969
0.230
Why?
Face
2
1997
46
0.210
Why?
Perception
1
2012
64
0.210
Why?
Exercise Test
1
2012
105
0.210
Why?
Genetic Testing
2
2008
102
0.210
Why?
Neuromuscular Diseases
1
2011
54
0.200
Why?
Infant
6
1983
2249
0.200
Why?
Complementary Therapies
1
2011
36
0.200
Why?
Health Status Indicators
1
2011
108
0.200
Why?
Neurologic Examination
1
2011
142
0.190
Why?
DNA Mutational Analysis
2
2006
189
0.190
Why?
Treatment Failure
1
2011
130
0.190
Why?
Muscle Contraction
3
1983
177
0.190
Why?
Insulin-Like Growth Factor Binding Protein 3
1
2010
17
0.190
Why?
Psychometrics
1
2011
221
0.190
Why?
Kaplan-Meier Estimate
1
2011
224
0.190
Why?
Point Mutation
2
1996
175
0.190
Why?
Biopsy
2
2006
359
0.190
Why?
Albuterol
2
1998
23
0.180
Why?
Anti-Inflammatory Agents
1
2011
116
0.180
Why?
Aged
8
1989
7272
0.180
Why?
Healthcare Disparities
1
2011
78
0.180
Why?
Adrenergic beta-Agonists
2
1998
55
0.180
Why?
Insulin-Like Growth Factor I
1
2010
106
0.180
Why?
Spinal Muscular Atrophies of Childhood
1
2009
12
0.170
Why?
Adrenal Cortex Hormones
1
2010
99
0.170
Why?
Palliative Care
1
2011
159
0.170
Why?
Gene Duplication
1
2008
9
0.170
Why?
Dystrophin
1
2008
13
0.170
Why?
Gene Frequency
1
2008
87
0.170
Why?
Genetic Markers
1
2008
132
0.160
Why?
Drug Eruptions
1
2008
27
0.160
Why?
Patient Care Team
1
2009
194
0.160
Why?
Health Knowledge, Attitudes, Practice
1
2011
279
0.160
Why?
Clinical Protocols
2
1994
105
0.160
Why?
Recombinant Proteins
1
2010
768
0.150
Why?
Joints
2
1981
61
0.150
Why?
Disability Evaluation
1
2008
120
0.150
Why?
Software
2
1987
125
0.150
Why?
Nifedipine
1
1987
33
0.150
Why?
Antibodies
1
2008
216
0.150
Why?
Muscular Dystrophies, Limb-Girdle
1
2006
4
0.150
Why?
Extremities
1
1997
34
0.150
Why?
Abstracting and Indexing as Topic
1
2006
10
0.150
Why?
Electrodiagnosis
1
2007
50
0.150
Why?
Genes, Dominant
1
1997
80
0.150
Why?
Time Factors
10
1984
3201
0.140
Why?
Risk Assessment
2
2005
878
0.140
Why?
Longitudinal Studies
2
2011
390
0.140
Why?
Data Collection
1
2006
214
0.130
Why?
Action Potentials
1
2007
256
0.130
Why?
Creatine Kinase
3
1981
58
0.110
Why?
Clinical Trials as Topic
9
1981
675
0.110
Why?
Arm
2
1997
55
0.110
Why?
Questionnaires
3
2011
998
0.110
Why?
Single-Blind Method
1
2002
118
0.100
Why?
Weight Gain
4
1991
53
0.100
Why?
rev Gene Products, Human Immunodeficiency Virus
1
2001
2
0.100
Why?
Oxandrolone
1
2001
4
0.100
Why?
HIV Long Terminal Repeat
1
2001
10
0.100
Why?
Anabolic Agents
1
2001
15
0.100
Why?
DNA, Recombinant
1
2001
40
0.100
Why?
Virus Assembly
1
2001
17
0.100
Why?
Genes, Viral
1
2001
83
0.100
Why?
Response Elements
1
2001
79
0.100
Why?
Follow-Up Studies
5
1985
1857
0.100
Why?
Transgenes
1
2001
74
0.100
Why?
Viral Envelope Proteins
1
2001
90
0.090
Why?
Reproducibility of Results
4
1992
884
0.090
Why?
Models, Genetic
1
2001
160
0.090
Why?
Muscle Fatigue
1
1999
11
0.090
Why?
Cloning, Molecular
1
2001
487
0.090
Why?
Iowa
2
2006
8
0.090
Why?
Colorado
2
2006
14
0.090
Why?
Arizona
2
2006
23
0.090
Why?
DNA, Viral
1
2001
305
0.090
Why?
Viral Proteins
1
2001
217
0.090
Why?
Contracture
4
1983
26
0.080
Why?
Cell Division
1
2001
766
0.080
Why?
Activities of Daily Living
2
2008
255
0.080
Why?
Multiple Sclerosis
1
1999
130
0.080
Why?
Randomized Controlled Trials as Topic
1
2010
409
0.080
Why?
United States
3
2006
2630
0.070
Why?
Infant, Newborn
1
2002
1831
0.070
Why?
Transcription, Genetic
1
2001
815
0.070
Why?
Cell Line
1
2001
1594
0.070
Why?
Disease Progression
2
1997
519
0.070
Why?
Random Allocation
4
1987
254
0.070
Why?
Diagnosis, Differential
2
2007
878
0.060
Why?
New York
2
2006
1282
0.060
Why?
Computers
2
1981
81
0.060
Why?
Respiratory Function Tests
3
1987
122
0.060
Why?
Prospective Studies
3
1987
1677
0.060
Why?
Retrospective Studies
2
2009
2260
0.060
Why?
Evaluation Studies as Topic
2
1984
243
0.060
Why?
Azathioprine
1
1993
20
0.060
Why?
Electromyography
3
1987
174
0.050
Why?
Chloride Channels
1
2012
72
0.050
Why?
Georgia
1
2011
14
0.050
Why?
Diagnosis, Computer-Assisted
1
2012
66
0.050
Why?
Sodium Channels
1
2012
124
0.050
Why?
Qualitative Research
1
2011
55
0.050
Why?
Great Britain
1
2011
98
0.050
Why?
Interview, Psychological
1
2011
76
0.050
Why?
Employment
1
2011
68
0.050
Why?
Family Health
1
2011
90
0.050
Why?
Hispanic Americans
1
2011
93
0.050
Why?
Linear Models
1
2011
235
0.050
Why?
Injections, Subcutaneous
1
2010
94
0.050
Why?
Drug Combinations
1
2010
151
0.050
Why?
Physical Therapy Specialty
1
2009
1
0.050
Why?
Language Disorders
1
2009
15
0.050
Why?
Nutritional Requirements
1
2009
15
0.050
Why?
Respiration Disorders
1
2009
6
0.050
Why?
Attitude to Health
1
2012
209
0.050
Why?
Gastrointestinal Diseases
1
2009
36
0.040
Why?
Aged, 80 and over
2
2006
2513
0.040
Why?
European Continental Ancestry Group
1
2011
226
0.040
Why?
Exercise Therapy
1
2009
36
0.040
Why?
Bone Diseases
1
2009
43
0.040
Why?
Pain Management
1
2009
50
0.040
Why?
Early Diagnosis
1
2009
29
0.040
Why?
African Americans
1
2011
214
0.040
Why?
Penicillamine
1
1988
26
0.040
Why?
Age of Onset
1
2009
122
0.040
Why?
Heart Diseases
1
2009
145
0.040
Why?
Ambulatory Care
1
2009
152
0.040
Why?
Placebo Effect
1
2008
34
0.040
Why?
Internationality
1
2008
27
0.040
Why?
Vitamin E
1
1988
89
0.040
Why?
Testosterone
1
1989
165
0.040
Why?
Motor Activity
1
2009
184
0.040
Why?
Muscle Relaxation
1
2007
23
0.040
Why?
Placebos
2
1993
182
0.040
Why?
Trinucleotide Repeats
1
2007
41
0.040
Why?
Evidence-Based Medicine
1
2009
199
0.040
Why?
Creatinine
2
1981
132
0.040
Why?
Needles
1
2007
45
0.040
Why?
Dystroglycans
1
2006
5
0.040
Why?
Caveolin 1
1
2006
14
0.040
Why?
Body Composition
1
1997
73
0.040
Why?
Leg
1
2007
97
0.040
Why?
Animals
2
1999
16270
0.040
Why?
Organ Size
1
1997
194
0.040
Why?
Chromosomes, Human, Pair 4
1
1996
35
0.040
Why?
Immunophenotyping
1
2006
124
0.040
Why?
Blotting, Southern
1
1996
101
0.040
Why?
Comorbidity
1
2008
374
0.030
Why?
Calpain
1
2006
43
0.030
Why?
Pain
1
2009
382
0.030
Why?
Incidence
1
2008
679
0.030
Why?
Muscle Proteins
1
2006
150
0.030
Why?
Time
1
2005
46
0.030
Why?
Predictive Value of Tests
1
2007
601
0.030
Why?
Sensitivity and Specificity
1
2008
905
0.030
Why?
Leucine
1
1984
109
0.030
Why?
Prevalence
1
2006
541
0.030
Why?
Movement
1
1985
165
0.030
Why?
Blotting, Western
1
2006
668
0.030
Why?
Body Weight
2
1991
338
0.030
Why?
Phenotype
1
1996
762
0.030
Why?
Motor Skills
1
1983
45
0.030
Why?
Respiration
1
1983
181
0.030
Why?
Membrane Proteins
1
2006
553
0.030
Why?
Muscle Tonus
1
2001
10
0.030
Why?
Carnitine
1
1981
15
0.020
Why?
Quality Control
1
1981
69
0.020
Why?
Risk Factors
1
2008
2318
0.020
Why?
Body Mass Index
1
2001
211
0.020
Why?
Statistics, Nonparametric
1
2001
256
0.020
Why?
Drug Therapy, Combination
2
1988
390
0.020
Why?
Models, Biological
1
1994
1023
0.020
Why?
Absorptiometry, Photon
1
1998
32
0.020
Why?
Age Factors
1
1981
1121
0.020
Why?
Research Design
2
1987
333
0.020
Why?
Biomechanics
1
1994
183
0.010
Why?
Body Height
1
1993
50
0.010
Why?
Pain Measurement
1
1994
243
0.010
Why?
Observer Variation
1
1992
143
0.010
Why?
Wheelchairs
1
1989
5
0.010
Why?
Locomotion
1
1989
29
0.010
Why?
Acne Vulgaris
1
1989
16
0.010
Why?
Cardiomyopathies
1
1989
85
0.010
Why?
Analysis of Variance
1
1991
725
0.010
Why?
Scoliosis
1
1989
50
0.010
Why?
Drug Evaluation
1
1987
101
0.010
Why?
Mice
1
1999
6103
0.010
Why?
Cost-Benefit Analysis
1
1987
209
0.010
Why?
Enzymes
1
1984
28
0.010
Why?
Methods
1
1984
220
0.010
Why?
Methylhistidines
1
1981
12
0.010
Why?

Visualizations


Pandya's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department